# Cynapsus Therapeutics Inc.: Form D filings

Cynapsus Therapeutics Inc., a pharmaceuticals company in Toronto, Ontario, Canada, filed 10 Form D notices with the SEC between 2011 and 2015. The latest, on April 14, 2015, reports $16.8 million sold of a $16.8 million offering to 14 investors.

Find out what Cynapsus Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Cynapsus%20Therapeutics%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Cynapsus%20Therapeutics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcynapsus-therapeutics-inc-1532079)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Cynapsus%20Therapeutics%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Cynapsus%20Therapeutics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcynapsus-therapeutics-inc-1532079)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 828 RICHMOND STREET WEST, Toronto, Ontario, Canada, M6J 1
- Phone: (416) 703-2449
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Canada (Federal Level)
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1532079

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 14, 2015 | New notice | $16,750,000 | $16,750,000 | $0 | 14 | Mar 31, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1532079/000153207915000001/0001532079-15-000001-index.htm) |
| Apr 21, 2014 | New notice | $42,916,967 | $14,546,285 | $28,370,682 | 19 | Apr 15, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1532079/000153207914000002/0001532079-14-000002-index.htm) |
| Mar 27, 2013 | Amendment | $13,017,911 | $4,124,454 | $8,893,457 | 5 | Mar 1, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1532079/000153207913000003/0001532079-13-000003-index.htm) |
| Mar 20, 2013 | New notice | $2,449,104 | $0 | $2,449,104 | 10 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1532079/000153207913000002/0001532079-13-000002-index.htm) |
| Mar 15, 2013 | New notice | $11,225,543 | $3,923,190 | $7,302,353 | 5 | Mar 1, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1532079/000153207913000001/0001532079-13-000001-index.htm) |
| Mar 28, 2012 | Amendment | $939,505 | $939,505 | $0 | 7 | Sep 29, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1532079/000153207912000002/0001532079-12-000002-index.htm) |
| Jan 9, 2012 | Amendment | $761,610 | $761,610 | $0 | 6 | Sep 29, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1532079/000153207912000001/0001532079-12-000001-index.htm) |
| Dec 28, 2011 | Amendment | $555,358 | $555,358 | $0 | 5 | Sep 29, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1532079/000153207911000003/0001532079-11-000003-index.htm) |
| Nov 18, 2011 | Amendment | $389,144 | $389,144 | $0 | 3 | Sep 29, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1532079/000153207911000002/0001532079-11-000002-index.htm) |
| Oct 13, 2011 | New notice | $222,368 | $222,368 | $0 | 2 | Sep 29, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1532079/000153207911000001/0001532079-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Margaret Nan Hutchinson | Director |  |
| Andrew Williams | Executive Officer |  |
| Anthony Giovinazzo | Executive Officer, Director |  |
| Thierry D. Bilbault | Executive Officer |  |
| Tamar D. Howson | Director |  |
| Ronald Hosking | Director |  |
| Rochelle D. Stenzler | Director |  |
| Ilan Nan Oren | Director |  |
| Tomer Gold | Director |  |
| Perry Nan Molinoff | Director |  |

[Every Form D from the week of Apr 13, 2015](https://specstream.ai/data/form-d/week/2015-04-13) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Cynapsus Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).